Causation And Prognosis Analyses of Coronary Artery Diseases: A Longitudinal Cohort Study

NCT07480512 · tracked via the Priya Life Science China tracker

Sponsor

Sun Yat-sen University

Phase

Observational

Started

2013-01-01

Last updated

2026-03-18

Condition(s) studied

Coronary Artery Disease

Study summary

This study is a single-center, historical prospective cohort study including patients diagnosed with coronary artery diseases, including stable angina pectoris, unstable angina pectoris, non-ST-segment elevation myocardial infarction, ST-segment elevation myocardial infarction, latent coronary artery diseases and ischemic cardiomyopathy. The primary outcome of the study is all-cause and cardiovascular mortality. We aim to investigate associations of established or suspected cardiovascular risk factors and the outcome in population with coronary artery dieseases in this real-world cohort.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Patients over 18 years old; * Patients with clinical diagnosis of coronary artery diseases, including stable angina pectoris, unstable angina pectoris, non-ST-segment elevation myocardial infarction, ST-segment elevation myocardial infarction, latent coronary artery diseases and ischemic cardiomyopathy. Exclusion Criteria: * Patients unable to provide informed consent.

Primary outcome measure(s)

All-cause mortality — Through study completion, an average of 5 years
Death due to any cause after enrollment
Cardiovascular mortality — Through study completion, an average of 5 years]
Death due to cardiovascular causes

Trial sites (1)

Facility	City	Region	Status
The First Affiliated Hospital, Sun Yat-sen Univerity	Guangzhou	Guangdong	Recruiting

More Sun Yat-sen University trials in China

ACHP-THP vs EC-THP as Neoadjuvant Therapy for HER2-positive EBC Active, not recruiting

Combination of Concurrent Chemoradiotherapy With Surufatinib and Tislelizumab in Patients With Locally Advanced Non-Small Cell Lung Cancer Recruiting

Sintilimab and Linperlisib Combination Treatment in Relapsed or Refractory Extranodal Natural Killer/T Cell Lymphoma Recruiting

Phacotrabeculectomy Versus Phacogoniotomy (PVP) in Advanced Primary Angle-closure Glaucoma Active, not recruiting

Myeloprotection With Trilaciclib in Pan-cancer Population Starting soon

Other trials for the same condition

No-Touch Versus Conventional Saphenous Vein Harvesting Technique Active, not recruiting

CRUSTAL Study in China Active, not recruiting

IndObufen Versus asPirin After Coronary Drug-eluting Stent implantaTION in Elderly Patients With Acute Coronary Syndrome Recruiting

A Prospective Multicenter Real-World Registry of Quantitative Flow Ratio-Guided Coronary REvascularization and QuAlity evaLuation Starting soon

NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07480512 on ClinicalTrials.gov ↗ ← All trials in China